Wednesday, April 27, 2011

Updates

Well, it looks like AEZS has begun to move and thus my portfolio's recession period has ended. What has really surprised me though is that TLON.OB has skyrocketed these past few days, and I suppose I'm a bit sad I erased mention of it from my first blog. Yep, now I don't get the right to say that I picked it before the "pro's", but I suppose the fact that it's in my portfolio at a comparitively low $0.80 keeps the grin on my face.

TLON.OB was formerly Hana Biosciences I believe, and their lead drug is Marqibo which is targetted at ALL and has been expanded to cover a few other areas. My initial hesitance in mentioning it was due to what seemed like a stand still with the company. They were asked to work with the FDA to design a few experiments, their cash position wasn't as strong as I thought it should be, and honestly I didn't want the shame of it tanking after my public recommendation. Lesson learned: missed glory > shame. At least one other person benefitted though.

As for why it's suddenly on the move, I can only say that it must have a lot to do with the hype of "TooNiceStocks" initiating coverage on the stock. Naturally, Seekingalpha has also released an article mentioning the company. Aside from that nothing has truly changed that I have seen thus far, so whether the rocket will run out of full or burst through the exosphere I cant say, but hopefully the latter.

No comments:

Post a Comment